0 Comments

New Delhi, Oct 21 Drug firm Granules India on Monday said it has received approval from the US health regulator for Fexofenadine Hydrochloride tablets, used to treat allergy symptoms.

The approved product is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC.

Author

binutharakan5@gmail.com

Leave a Reply

Your email address will not be published. Required fields are marked *